Reaction
Lipoprotein (A) Increased reporting signals
As of the last recalculation, Lipoprotein (A) Increased appears in 293 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 329.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Inclisiran | 33 | 329.3 | 330.6 |
| Ezetimibe | 63 | 75.8 | 75.8 |
| Dapagliflozin | 30 | 75.4 | 75.4 |
| Indapamide | 13 | 53.9 | 53.9 |
| Ranolazine | 6 | 41.7 | 41.7 |
| Evolocumab | 69 | 39.2 | 39.2 |
| Methylphenidate | 12 | 30.7 | 30.7 |
| Alirocumab | 9 | 26.3 | 26.3 |